A phase 2 study of induction chemotherapy followed by chemoradiotherapy for patients with borderline resectable pancreatic cancer
Not Applicable
Recruiting
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000034410
- Lead Sponsor
- Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Contraindication of nab-PTX, GEM, TS-1 2) Pleuritic effusion refractory to diuretics 3) Presence of distant metastasis 4) Presence of concurrent advanced cancer 5) Presence of clinically obvious infection 6) Prior radiotherapy to abdominal lesions 7) Previous history of myocardial infarction within three months 8) Severely mental retardation 9) Current status of pregnancy and lactation, or the possibility of these statuses.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method